Kesin Pharma Logo (Kesin Logo)
Lacosamide Oral Solution
Product Images NDC 81033-427
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lacosamide Oral Solution (NDC 81033-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kesin Pharmaceutical Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lacosamide Os 10 mL Carton (Lacosamide Os 10ml 10ct Carton)
Label for Lacosamide Oral Solution, USP 100 mg per 10 mL, presented as 10 mL unit dose cups with a total of 10 cups per package. The label includes the NDC 81033-427, states Rx only, and indicates packaging by Kesin Pharmaceutical Corporation in Oldsmar, FL. Storage instructions specify 68°F to 77°F (20°C to 25°C). For institutional use only.*
Lacosamide Os 15 mL Carton (Lacosamide Os 15ml 10ct Carton)
Label for Lacosamide Oral Solution, USP 150 mg per 15 mL, an oral prescription solution packaged as 10 unit dose cups of 15 mL each. Distributed by Kesin Pharma Corporation, it is labeled for institutional use only and includes storage instructions at 68°F to 77°F (20°C to 25°C).*
Lacosamide Os 20 mL Carton (Lacosamide Os 20ml 10ct Carton)
Lacosamide Oral Solution, USP 200 mg per 20 mL, oral solution unit dose packaging label from Kesin Pharmaceutical Corporation. The label indicates 10 x 20 mL unit dose cups with storage temperature instructions (68°F to 77°F or 20°C to 25°C) and is marked for institutional use and prescription only.*
Lacosamide Os 5 mL Carton (Lacosamide Os 5ml 10ct Carton)
Label for Lacosamide Oral Solution USP 50 mg per 5 mL, an oral solution packaged as 10 x 5 mL unit dose cups. The label includes the NDC 81033-427-14, states Rx only, and indicates packaging and distribution by Kesin Pharma Corporation in Oldsmar, Florida. Storage instructions specify 68°F to 77°F (20°C to 25°C). The label is marked for institutional use only.*
Lacofig1 (Laco Fig 1)
A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' displaying seizure frequency reductions across three studies (Study 2, Study 3, Study 4). The vertical axis shows seizure reduction percentages from 0% to 45%. Each study compares placebo with different Lacosamide doses (200 mg/day, 400 mg/day, 600 mg/day) with corresponding patient numbers. Bars indicate higher median seizure reductions with increasing doses of Lacosamide compared to placebo, with some marked as statistically significant.*
Lacofig2a (Laco Fig 2a)
A line graph showing the proportion of patients by responder rate for Lacosamide Oral Solution and placebo groups across several dosage levels (200 mg/day, 400 mg/day, 600 mg/day). The x-axis represents the percent of patients, and the y-axis represents responder rate ranging from -100% (worsening) to 100% (improvement). Multiple lines compare placebo with different lacosamide doses in studies 2, 3, and 4.*
Lacostructure (Laco Structur)
Chemical structure of lacosamide, the active ingredient in Lacosamide Oral Solution 10 mg/mL by Kesin Pharmaceutical Corporation. The diagram depicts the molecule's bonds and functional groups in a skeletal formula style.*
Lacofig3 (Lacofig3)
A Kaplan-Meier survival curve comparing the proportion of patients surviving over time between two groups: Placebo (N=121) and Lacosamide (N=116). The graph shows survival percentages on the vertical axis and time in days on the horizontal axis, illustrating better survival in the Lacosamide group. Statistical data including p-value, hazard ratio, and confidence interval are displayed.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
